FindTrial
Sign In

Homoeopathic management of Ringworm with juglans regia 30C

A Prospective Interventional Study On The Effectiveness Of Juglans Regia 30C In The Symptomatic Management Of Tinea Corporis Assessed Through Clinical Symptom Score - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099372
Enrollment
36
Registered
2025-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Juglans regia 30C: 4 pills as 1 dose orally in first visit and 7th day one more dose will be given after 15 days while coming for follow up later repetition of dose will be done after e

Sponsors

JIMS Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: KOH mount will be done to confirm Tinea corporis

Exclusion criteria

Exclusion criteria: Use of systemic antifungals in the last 3 months and other applicants containing any medicinal properties other than coconut oil Immunocompromised patients pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
Elicit significant changes in clinical symptom score from baseline to post treatment after administration of juglans regia 30C orally in patients with Tinea corporis in 3 monthsTimepoint: base line and 3rd month—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public Contactkatheramalla laharika

JIMS homoepathic medical college and hospital

samarchattterjeee01@gmail.com8250798221

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026